• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Hester Biosciences Limited — Board Meeting, 11-03-2026: Outcome of Board Meeting

    11-03-2026 | 11:16 am

    Hester Biosciences' board has approved selling 43.81% stake in subsidiary Texas Lifesciences to existing promoters for ₹9.2 Cr. Hester will retain 11%. TLPL will cease to be a subsidiary.

    No comments yet. Be the first to comment!

    All announcements from Hester Biosciences Limited